18th Annual International Ultmann Chicago Lymphoma Symposium

April 30, 2021 to May 1, 2021
The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers.
This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. This year’s meeting will be held virtually on Friday and Saturday and will include a combination of expert presentations, a hematopathology multidisciplinary tumor board discussion, mini symposiums on Indolent lymphoma, aggressive lymphomas, primary and secondary CNS lymphoma, targeted and cellular therapies, and imaging. It will also include a session designed to meet the needs of advanced practice providers, nurses, and pharmacists. Additionally, we’ll have a special presentation regarding the impact of COVID-19 on lymphoma treatment.

Virtual symposium components will include:
  • Live stream session broadcast in real time;
  • Opportunities to submit questions to presenters during the live broadcast;
  • Ability to interact with other virtual participants via symposium participant chat tool;
  • Access to the virtual exhibit hall for connectivity and information;
  • CME and MOC credits for physicians and CNE credits for nurses;
  • Access to download presenter slide decks approved for release.
Learn more at the symposium website!                                                   

Target Audience

This activity is designed for medical hematologists/oncologists, radiation oncologists, pathologists, surgical oncologists, fellows-in-training, oncology nurses, and other healthcare professionals committed to the diagnosis and treatment of lymphoma.

Learning Objectives

At the conclusion of this educational activity, participants will be able to:

  • Evaluate strategies for the care of patients with indolent B-cell lymphoma and aggressive B-cell lymphoma subtypes;
  • Assess patient and disease-related factors that impact the selection and sequencing of agents for patients with CLL;
  • Review the safety and efficacy of recent clinical trial data of emerging agents being explored in patients with lymphoma;
  • Discuss the interplay between pathologists and clinicians in diagnosing various cases of patients with lymphoma.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
Conference Secretariat
CME Coordinator Contact Email: 
Available credit: 
  • 16.00 ABIM
  • 16.00 AMA PRA Category 1 Credit™
  • 16.00 Nursing Contact Hours
  • 16.00 Participation
Event starts: 
04/30/2021 - 1:00pm
Event ends: 
05/01/2021 - 5:00pm
Activity opens: 
Activity expires: 

18th Annual International Ultmann Chicago Lymphoma Symposium Agenda
18th Annual International Ultmann Chicago Lymphoma Symposium Agenda
18th Annual International Ultmann Chicago Lymphoma Symposium Agenda
Agenda subject to change.

Virtual Symposium
Chicago, IL
United States
Learn more about the program by visiting chicagolymphoma.com.
Please contact the Symposium Secretariat via e-mail here.

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via e-mail at iucls@bioascend.com.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

  Sonali M. Smith, MD
  Elwood V. Jensen Professor of Medicine
  Chief, Section of Hematology/Oncology
  Director, Lymphoma Program
  University of Chicago
  Andrew M. Evens, DO, MSc
  Professor of Medicine, Rutgers Robert Wood Johnson Medical School 
  Associate Director for Clinical Services, Rutger Cancer Institute of New Jersey
  Director, Lymphoma Program, Division of Blood Disorders 
  Medical Director, Oncology Service Line, RWJBarnabas Health
  Barbara Pro, MD
  Clinical Director, Lymphoma Program 
  Professor of Medicine
  Division of Hematology/Oncology
  Robert H. Lurie Cancer Center
  Northwestern University Feinberg School of Medicine

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 16 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit
The University of Chicago Medicine is an approved provider of continuing nursing education by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)

This live activity is designated for a maximum of 16 continuing nursing education units.
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits from organizations accredited by the ACCME, please consult your professional licensing board.

Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.

This conference offers an excellent opportunity to highlight your company products, services, and achievements in front of a wide array of key decision makers. Increase your company profile by participating as an exhibitor at this exciting event.
Download the prospectus PDF icon here or contact BioAscend at iucls@bioascend.com. We hope to see you there!

Preview conference fees below then click the button to register!

Physicians, Nurses, and Other Healthcare Professionals

 Access Type  
Friday & Saturday$75
Nursing Session Only$25
Friday Only$50
Saturday Only$50
Access TypeFee
Friday & Saturday$50
Access Type
Friday & Saturday
Friday Only
Saturday Only
All conference fees will be charged a non-refundable 3% credit card processing fee during registration.

CANCELLATION POLICY Any cancellations must be made in writing and sent to chaia@bioascend.com.

A registrant will receive a return of 50% (minus a processing fee) on refunds requested before April 1,  2021. No refunds will be made after May 1, 2021.

After the conference, create an account or log in and enter the access code to unlock the credit claiming process.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.

Please login or create an account to proceed.